Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene

Annals of Neurology

Volumn 43, Issue 6, 1998, Pages 703-710

  Cudkowicz, M E ^a   McKenna Yasek, D ^a   Chen, C ^b   Hedley Whyte, E T ^a   Brown Jr , R H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOTONEURON; PRIORITY JOURNAL; PYRAMIDAL TRACT; THORACIC SPINAL CORD;

ADULT; AGED; AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; MOTOR NEURONS; PHENOTYPE; POINT MUTATION; PYRAMIDAL TRACTS; SUPEROXIDE DISMUTASE;

EID: 0031814006     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430604     Document Type: Article

References (42)

1. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn Superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62
2. Cudkowicz M, McKenna-Yasek D, Sapp P, et al. Epidemiology of mutations in Superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997;41:210-221
3. Cudkowicz M, Brown R. An update on Superoxide dismutase in familial amyotrophic lateral sclerosis. J Neurol Sci 1996; 139(Suppl):10-15
4. Juneja T, Pericak-Vance M, Laing N, et al. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase. Neurology 1997;48:55-57
5. Radunovic A, Leigh P. Cu/Zn Superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry 1996;61:565-572
6. Orrell R, Habgood J, Gardiner I, et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc Superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 1997;48:746-751
7. Engel W, Kurland L, Klatzo I. An inherited disease similar to amyotrophic lateral sclerosis with a pattern of posterior column involvement. An intermediate form? Brain 1959;82:203-220
8. Tanaka J, Nakamura H, Tabuchi Y, Takahashi K. Familial amyotrophic lateral sclerosis: features of multisystem degeneration. Acta Neuropathol 1984;64:22-29
9. Brownell B, Oppenheimer D, Hughes J. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970;33:338-357
10. Lawyer T, Netsky M. Amyotrophic lateral sclerosis: a clinicoanatomic study of 53 cases. Arch Neurol Psychiatry 1953;69: 171-192
11. Abe K, Aoki M, Ikeda M, et al. Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn Superoxide dismutase gene mutations. J Neurol Sci 1996;136:108-116
12. Enayat ZE, Orrell RW, Claus A, et al. Two novel mutations in the gene for copper zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Hum Mol Genet 1995;4: 1239-1240
13. Takahashi H, Makifuchi T, Nakano R, et al. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn Superoxide dismutase gene. Acta Neuropathol 1994;88:185-188
14. Rainero I, Pinessi L, Tsuda T, et al. SOD1 missense mutation in a Italian family with ALS. Neurology 1994;44:347-349
15. Aoki M, Abe K, Houi K, et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn Superoxide dismutase mutation. Ann Neurol 1995;37:676-679
16. Aoki M, Ogasawara M, Matsubara Y, et al. Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn Superoxide dismutase gene: a possible new subtype of familial ALS. J Neurol Sci 1994;126:77-83
17. Robberecht W, Aguirre T, Can Dne Bosch L, et al. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 1996;47:1336-1339
18. Calder V, Domigan N, George P, et al. Superoxide dismutase (glu100 gly) in a family with inherited motor neuron disease: detection of mutant Superoxide dismutase activity and the presence of heterodimers. Neurosci Lett 1995;189:143-146
19. Orrell R, Habgood J, Rudge P, et al. Difficulties in distinguishing sporadic from familial amyotrophic lateral sclerosis. Ann Neurol 1996;39:810-812
20. Ikeda M, Abe K, Aoki M, et al. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn Superoxide dismutase gene. Neurology 1995; 45:2038-2042
21. Orrell R, de Belleroche J, Marklund S, et al. A novel SOD mutant and ALS. Nature 1995;374:504-505
22. Rouleau G, Clatk A, Rooke K, et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 1996;39:128-131
23. Ince P, Shaw P, Slade J, et al. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn Superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol 1996;92:395-403
24. Orrell RW, King AW, Hilton DA, et al. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry 1995;59:266-270
25. Andersen P, Nilsson P, Keranen M, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997;120:1723-1737
26. Kato S, Shimoda M, Watanabe Y, et al. Familial amyotrophic lateral sclerosis with a two base pair deletion in Superoxide dismutase 1 gene: multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J Neuropathol Exp Neurol 1996;55:1089-1101
27. Brooks B. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial. Clinical limits of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(Suppl): 96-107
28. Osier W. Heredity in progressive muscular atrophy as illustrated in Farr family of Vermont. Arch Med 1880;4:316-320
29. Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. Neurology 1955;5:249-268
30. Hirano A, Kurland L, Sayre G. Familial amyotrophic lateral sclerosis. Arch Neurol 1967;16:232-243
31. Brown M. "Wetherbee Ail": The inheritance of progressive muscular atrophy as a dominant trait in two New England families. N Engl J Med 1951;245:645-647
32. Shibata N, Hirano A, Kobayahi M, et al. Intense Superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 1996;55:481-490
33. Uyama E, Hirano A. Neuropathology of familial amyotrophic lateral sclerosis with mutant SOD1 in light of transgenic mouse model. In: Nakano I, Hirano A, eds. Amyotrophic lateral sclerosis: progress and perspectives in basic research and clinical application. New York: Elsevier, 1996
34. Kato T, Hirano A, Kurlant L. Asymmetric involvement of the spinal cord involving both large and small anterior horn cells in a case of familial amyotrophic lateral sclerosis. Neuropathology 1987;6:67-70
35. Kato S, Hayashi H, Nakashima K, et al. Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis. Am J Pathol 1997;151:611-620
36. Ikeda M, Abe K, Ogasawara M, et al. A novel point mutation in the Cu/Zn superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995;4: 491-492
37. Brown R. Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function. Curr Opin Neurobiol 1995;5:841-846
38. Bowling AC, Schulz JB, Brown RH Jr, Beal MF. Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993;61:2322-2325
39. Siddique TS, Figlewicz DA, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991;324:1381-1384
40. Robberecht W, Sapp P, Viaene MK, et al. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1994;62:384-387
41. Andersen PM, Nilsson P, Ala-Hurula V, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Als mutation in CuZn-superoxide dismutase. Nat Genet 1995;10: 61-65
42. Watanabe M, Aoki M, Abe K, et al. A novel missense point mutation (S134N) of the Cu/Zn superoxide dismutase gene in a patients with familial motor neuron disease. Hum Mutat 1997;9:69-71